Lu Jianghai, Wang Xiaobing, Yang Shuming, Liu Xin, Qin Yang, Shen Li, Wu Yun, Xu Youxuan, Wu Moutian, Ouyang Gangfeng
National Doping Control Laboratory, China Anti-Doping Agency, 1st Anding Road, ChaoYang District, Beijing 100029, PR China.
Rapid Commun Mass Spectrom. 2009 Jun;23(11):1592-600. doi: 10.1002/rcm.4044.
A new and reliable two-step liquid chromatography/tandem mass spectrometry (LC/MS/MS) method in combination with gas chromatography/mass spectrometry (GC/MS) for the screening and confirmation of adrafinil and its major metabolites, modafinil and modafinil acid, in human urine has been developed and validated. The method involved reversed-phase C18 solid-phase extraction (SPE) cartridge extraction and MS analysis by means of LC/MS/MS and GC/MS. The study illustrated that the ESI capillary temperature played a key role in the formation of the protonated molecule. The limits of detection (LODs) of the developed method for the three compounds were lower than the minimum required performance limit (MRPL) of the World Anti-Doping Agency (WADA). The human urine samples obtained after the oral administration of modafinil and from the Beijing 2008 Olympic Games were analyzed by using the described method, which has also been successfully applied to routine analyses and the WADA Proficiency Test.
已开发并验证了一种新型可靠的两步液相色谱/串联质谱(LC/MS/MS)方法,该方法结合气相色谱/质谱(GC/MS)用于筛查和确证人体尿液中的阿屈非尼及其主要代谢物莫达非尼和莫达非尼酸。该方法包括反相C18固相萃取(SPE)柱萃取以及通过LC/MS/MS和GC/MS进行质谱分析。研究表明,电喷雾离子化(ESI)毛细管温度在质子化分子的形成中起关键作用。所开发方法对这三种化合物的检测限低于世界反兴奋剂机构(WADA)的最低所需性能限度(MRPL)。使用所述方法对口服莫达非尼后获得的人体尿液样本以及来自北京2008年奥运会的样本进行了分析,该方法也已成功应用于常规分析和WADA能力验证测试。